|
ZNF610 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.795200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.481600E-01 |
| Normal-vs-Stage2 |
9.940800E-01 |
| Normal-vs-Stage3 |
8.547000E-01 |
| Normal-vs-Stage4 |
2.613400E-01 |
| Stage1-vs-Stage2 |
9.639200E-01 |
| Stage1-vs-Stage3 |
8.121600E-01 |
| Stage1-vs-Stage4 |
4.088000E-01 |
| Stage2-vs-Stage3 |
8.976800E-01 |
| Stage2-vs-Stage4 |
4.898200E-01 |
| Stage3-vs-Stage4 |
5.430800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.438600E-01 |
| Normal-vs-AfricanAmerican |
8.779800E-01 |
| Normal-vs-Asian |
1.355570E-02 |
| Caucasian-vs-AfricanAmerican |
6.185200E-01 |
| Caucasian-vs-Asian |
6.839900E-02 |
| AfricanAmerican-vs-Asian |
5.913500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.260400E-01 |
| Normal-vs-Female |
2.030200E-01 |
| Male-vs-Female |
1.710150E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.718800E-01 |
| Normal-vs-Extreme_Weight |
2.449200E-01 |
| Normal-vs-Obese |
1.435370E-01 |
| Normal-vs-Extreme_Obese |
6.537000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.935400E-01 |
| Normal_Weight-vs-Obese |
1.827820E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.190800E-01 |
| Extreme_Weight-vs-Obese |
1.649980E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.873000E-01 |
| Obese-vs-Extreme_Obese |
7.757800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.627800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.365000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.126000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.438000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.617400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.794600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.318800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.455800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.615700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.885950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.010000E-01 |
| Normal-VS-Type2 PRCC |
2.697800E-02 |
| Normal-VS-KIRP CIMP |
1.697960E-01 |
| Normal-VS-Unclassified PRCC |
8.738200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.26060000000561E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.078200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.780390E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.893500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.497360E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.053600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.990400E-01 |
| Normal-vs-N1 |
2.790800E-01 |
| Normal-vs-N2 |
2.060200E-02 |
| N0-vs-N1 |
1.092440E-01 |
| N0-vs-N2 |
2.239600E-01 |
| N1-vs-N2 |
1.281440E-01 |
|
|
